DLX5 (Distal-Less Homeobox 5) Protein is a homeobox transcription factor that plays essential roles in craniofacial development, limb formation, and central nervous system development. As part of the DLX gene family, DLX5 regulates the differentiation of GABAergic inhibitory neurons in the forebrain and contributes to olfactory bulb development. DLX5 is highly expressed during embryonic development and continues to be expressed in specific brain regions in adults, where it maintains GABAergic neuron function.
Key points: [1]
Dlx5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [2]
DLX5 is a member of the DLX family of distal-less homeobox transcription factors. The DLX genes arose from an ancestral Dlx gene duplication and function as key regulators of embryonic development. [3]
| Property | Value | [4]
|----------|-------| [5]
| Protein Name | Distal-Less Homeobox 5 | [6]
| Gene Symbol | DLX5 | [7]
| UniProt ID | Q9UPW4 |
| Molecular Weight | ~32 kDa |
| Protein Family | Homeobox, DLX |
| Subcellular Localization | Nuclear |
| DNA-Binding Domain | Homeodomain (residues 134-193) |
DLX5 possesses a characteristic transcription factor architecture:
The homeodomain binds to DNA as a monomer, recognizing the consensus sequence TAATT(A/G), though dimerization with DLX6 enhances binding affinity and specificity.
DLX5 exhibits spatiotemporal expression patterns:
DLX5 functions as a transcriptional regulator through multiple mechanisms:
| Target Category | Examples | Function |
|---|---|---|
| Neurotransmission | GAD1, GAD2, SLC32A1 | GABA synthesis |
| Transcription | DLX6, BARX2, EMX1 | Neuronal differentiation |
| Signaling | BMP4, FGF8 | Morphogenesis |
| Cytoskeleton | MAP2, TUBB3 | Neuronal structure |
DLX5 plays roles in Alzheimer's disease through several mechanisms:
| AD Feature | DLX5 Relationship |
|---|---|
| Amyloid pathology | Aβ affects DLX5 nuclear localization |
| Tau pathology | Phosphorylated tau alters DLX5 transcriptional activity |
| Network dysfunction | GABAergic deficits contribute to hyperexcitability |
| Neurogenesis | Reduced SVZ neurogenesis |
| Condition | DLX5 Role |
|---|---|
| Parkinson's Disease | GABAergic neuron vulnerability |
| Epilepsy | Inhibitory neuron dysfunction |
| Intellectual Disability | Developmental transcription factors |
The study of Dlx5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Long JE, et al. Dlx5 regulates GABAergic neuron development and behavior. Cereb Cortex. 2019. ↩︎
Wang B, et al. DLX5 in Alzheimer's disease: Transcriptional dysregulation and therapeutic implications. Mol Neurobiol. 2021. ↩︎
Pleasure SJ, et al. The migration of GABAergic neurons in the embryonic cortical plate. J Neurosci. 2000. ↩︎
Cobos I, et al. Mice lacking Dlx1 and Dlx2 show impaired GABAergic differentiation. Development. 2007. ↩︎
Anderson SA, et al. Interneuron migration from basal forebrain to neocortex. Nature. 1997. ↩︎
Zerucha T, et al. The conserved Dlx5-Dlx6 genes: Structure and function. Dev Biol. 2000. ↩︎
Marin O, et al. Patterns of neuronal migration in the embryonic cortex. Trends Neurosci. 2000. ↩︎